Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure

Table 4 Follicle-stimulating hormone concentration of each group at each time point

Items	Before transplantation	After transplantation
		1 d	15 d	30 d	45 d	60 d
Negative control group	8.61 ± 0.03	9.25 ± 0.35	8.64 ± 0.56	9.27 ± 0.36	8.93 ± 0.26	9.11 ± 0.10
Model group	8.76 ± 0.17 (P = 0.19)	18.33 ± 0.79	20.36 ± 0.74	22.38 ± 1.05	24.26 ± 1.15	25.19 ± 0.96
hUCMSC group	8.70 ± 0.38 (P = 0.93)	19.44 ± 1.23	14.07 ± 0.53	15.52 ± 0.57	18.22 ± 1.14	18.55 ± 0.66
Positive control group	8.66 ± 0.45 (P = 0.10)	18.5 ± 0.31	12.50 ± 0.63	12.39 ± 0.03	13.50 ± 1.04	14.28 ± 0.64
P value	P > 0. 05

hUCMSC: Human umbilical cord mesenchymal stem cell.